89 of 89 results found
According to the European Pharmaceutical Review, the UK Competition and Markets Authority (CMA) has set up a task force to track retailers who have used the outbreak of coronavirus to raise drug prices.
Financial Times has reported that the American pharmaceutical company AbbVie (EbbVi) was the first to take a radical step by abandoning the global patent rights for the antiretroviral drug Kaletra (lopinavir/ritonavir), which is undergoing clinical trials for the treatment of coronavirus infection SARS-CoV-2.
Legal Advisor to the Government of Israel Avihai Mandelblit for the first time authorized the use of generic drugs, where a patent for the original drug has not yet expired. Mandelblit justified his decision with the fight against the coronavirus COVID-2019. Now, generics of the antiretroviral medication Kaletra (lopinavir + ritonavir) from AbbVie can be imported into the country.
On March 13, the BRICS Antimonopoly Center, together with the FAS Russia, held a meeting of the BRICS working group on competition in the pharmaceutical markets.
The US Congress is continuing to call for activity in the field of antitrust legislation and enforcement. It is not surprising that one of the significant areas of interest in antitrust enforcement in the IT sector.
French authorities found Apple guilty of violating antitrust laws and price conspiracy. Now Apple has to pay the largest fine in the history of the French competition authority.
Today, as of the 12th of March, the amendments to the 'antitrust compliance' bill came into force under Federal Law of the 1st of March, 2020 No. 33-FL.
The department received a complaint about the advertising of Arbidol. Following the complaint, at the end of January, the antimonopoly department was going to check the advertisement of the Arbidol drug containing a statement about the effectiveness of the drug in the fight against coronavirus.

Recently The New York Times has reported that a petition signed by multiple labour unions, including one of the largest - the International Brotherhood of Teamsters, was submitted to the Federal Trade Commission. The petition was filed in order to push for the investigation of Amazon's anticompetitive behaviour and to study Amazon's impact on the economy overall.
RIA News has published the information stating that it was informed by the press department of The Federal Antimonopoly Service (FAS) of Russia, that in light of the depreciation of the ruble, reminded that it continually monitors prices for socially significant goods.
According to Reuters, Brazilian Prosecutor General's Office has filed a request with the Antimonopoly Authority of the country (CADE) to conduct an additional audit of the sale of the national aircraft manufacturer Embraer to the American aircraft manufacturer Boeing.
According to the amendments to the law "On Protection of Competition", prepared by the FAS in mid-February, the agency proposed to withdraw the "immunity" from software developers. This means that the application of antitrust laws to the results of intellectual activity in the software sector will become possible, thus expanding the regulatory powers in digital markets.
The Federal Antimonopoly Service has prepared a draft decree of the Government of the Russian Federation "On the methodology for determining the amount of compensation paid to the patent holder when deciding on the use of an invention, utility model or industrial design without his consent, and the procedure for its payment". The document was published on the portal. Public discussion will last until March 19, 2020.
The state Duma adopted a bill that enshrines the concept of "an internal system to ensure compliance with antitrust laws" (antitrust compliance).
CADE has presented the Annual report on performance in the defense of competition in 2019. During the Annual report launch, the CADE's president, Alexandre Barreto, highlighted that 2019 was the year of consolidation of the institutional and structural changes, which took the defense of competition to new heights in Brazil.
Advocate General of the European Court of Justice, Juliane Kokott expressed the view that the judicial authority should support the decision of UK Competition and Market Authority that transactions to delay the entry into the market of generics (pay-for-delay) between GlaxoSmithKline and other companies are in violation of antitrust laws, FirstWord Pharma reports.
According to the reports by The Wall Street Journal, the European Commission has launched a preliminary antitrust investigation against Facebook, suspecting the corporation of surveillance and elimination of potential competitors. The publication reports that the European regulator is currently investigating the statements of numerous companies that Facebook uses the personal data of its users to weed out competitors.
The Federal Antimonopoly Service (FAS) of Russia has recorded complaints from citizens about the rise in the price of several products amid a decline in imports from China due to coronavirus. Mr Andrey Tsyganov, the deputy head of the FAS Russia has commented on the situation with the following statement - "We see reports about prices rising for some products, but not from reports of our territorial administrations, but the media and citizens".
Show more...